Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerbrig Berger

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cell Death & Disease|October 27, 2017
CITED2 affects leukemic cell survival by interfering with p53 activationKatharina Mattes, Gerbrig Berger, Marjan Geugien, et al.
Blood|January 10, 2018
Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCTGerbrig Berger, Leonie I Kroeze, Theresia N Koorenhof-Scheele, et al.
Blood Advances|October 25, 2019
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression patternGerbrig Berger, Mylene Gerritsen, Guoqiang Yi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cell Death & Disease|October 27, 2017
CITED2 affects leukemic cell survival by interfering with p53 activationKatharina Mattes, Gerbrig Berger, Marjan Geugien, et al.
Blood|January 10, 2018
Early detection and evolution of preleukemic clones in therapy-related myeloid neoplasms following autologous SCTGerbrig Berger, Leonie I Kroeze, Theresia N Koorenhof-Scheele, et al.
Blood Advances|October 25, 2019
Ring sideroblasts in AML are associated with adverse risk characteristics and have a distinct gene expression patternGerbrig Berger, Mylene Gerritsen, Guoqiang Yi, et al.
Pageof 1